By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > ACE inhibitor > Perindopril

Perindopril

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|680 words

What is Perindopril?

Perindopril is a prescription medication belonging to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. It is primarily used to treat high blood pressure (hypertension) and certain heart conditions by helping blood vessels relax and widen. This medication is available in tablet form and requires a prescription from a healthcare provider.

Uses

Perindopril is approved for several cardiovascular conditions:

High blood pressure (hypertension): The primary use of perindopril is to lower elevated blood pressure, either as a standalone treatment or in combination with other blood pressure medications.

Heart failure: It helps improve symptoms and reduces hospitalizations in patients with heart failure by reducing the workload on the heart.

Submit Your Paper
GMJ_Submit_Banner

Coronary artery disease: Perindopril is used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with stable coronary artery disease.

Diabetic kidney disease: The medication helps protect kidney function in diabetic patients by reducing protein loss in the urine and slowing the progression of kidney damage.

Post-heart attack treatment: It may be prescribed following a heart attack to improve survival rates and prevent future cardiovascular events.

How it works

Perindopril works by blocking the action of angiotensin-converting enzyme (ACE), which is responsible for producing a hormone called angiotensin II. Angiotensin II normally causes blood vessels to narrow and triggers the release of another hormone that increases fluid retention. By inhibiting ACE, perindopril allows blood vessels to relax and widen, reducing blood pressure and decreasing the workload on the heart.

Side effects

Common side effects include:

  • Dry, persistent cough
  • Dizziness or lightheadedness
  • Headache
  • Fatigue or weakness
  • Nausea
  • Low blood pressure symptoms
  • Elevated potassium levels
  • Changes in taste

Serious side effects to watch for:

  • Severe allergic reactions with swelling of face, lips, tongue, or throat
  • Kidney problems or decreased kidney function
  • Dangerously high potassium levels
  • Severe drop in blood pressure
  • Liver problems

Warnings and precautions

Pregnancy and breastfeeding: Perindopril should not be used during pregnancy as it can cause serious harm or death to the developing fetus. Women should inform their doctor if they become pregnant while taking this medication.

Kidney disease: Patients with kidney problems require careful monitoring and possible dose adjustments, as ACE inhibitors can affect kidney function.

Liver disease: Those with liver impairment may need reduced doses since the medication is processed by the liver.

Dehydration and electrolyte imbalances: Patients who are dehydrated, on a low-salt diet, or taking diuretics may be at higher risk for excessive blood pressure drops.

Surgery and anesthesia: Patients should inform their healthcare providers about perindopril use before any surgical procedures, as it may interact with anesthesia.

Interactions

Potassium supplements and salt substitutes: Can lead to dangerous increases in blood potassium levels when combined with perindopril.

Diuretics (water pills): May cause excessive blood pressure reduction, especially when starting treatment.

NSAIDs (ibuprofen, naproxen): Can reduce the effectiveness of perindopril and increase the risk of kidney problems.

Lithium: Perindopril can increase lithium levels in the blood, potentially leading to lithium toxicity.

Diabetes medications: ACE inhibitors may enhance the blood sugar-lowering effects of insulin and oral diabetes drugs.

Potassium-sparing diuretics: Increases the risk of elevated potassium levels in the blood.

Allopurinol: May increase the risk of serious allergic reactions when used with ACE inhibitors.

Gold injections: Rarely, may cause flushing, nausea, and low blood pressure when combined with ACE inhibitors.

Check interactions with the GMJ Interaction Checker

Dosage

For adults with high blood pressure, the typical starting dose is 4 mg once daily, which may be increased to 8 mg daily based on blood pressure response. For heart failure, treatment usually begins with 2 mg once daily, gradually increasing as tolerated. In coronary artery disease, the typical maintenance dose is 8 mg once daily. Elderly patients and those with kidney problems may require lower starting doses. Dosage should always be determined and monitored by a healthcare provider, who will adjust the dose based on individual response and medical conditions.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Perindopril." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/perindopril-3/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How a single stem cell in bone marrow generates your entire immune system

All blood and immune cells originate from a single pluripotent hematopoietic stem…

How amino acids shape brain function: neurotransmitters, energy, and cognitive resilience

Amino acids are the precursors to neurotransmitters and metabolic substrates for brain…

How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Enalapril

By
Prof. Giorgi Pkhakadze
01/06/2026

Benazepril

By
Prof. Giorgi Pkhakadze
01/06/2026

Perindopril

By
Prof. Giorgi Pkhakadze
01/06/2026

Lisinopril

By
Prof. Giorgi Pkhakadze
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up